Table 1 Nutritional parameters of different sub-groups at the end of the second stage of the experiment.

From: Management of metabolic syndrome by nutraceuticals prepared from chitosan and ferulic acid with or without beta-sitosterol and their nanoforms

Groups

Parameters

IBW (g)

FBW (g)

BWG (g)

TFI (g)

FER

NC

207.5a ± 4.4

246.8a ± 3.57

39.3a ± 1.46

378.3a ± 13.04

0.104a ± 0.005

MC

255.0b ± 3.3

313.6b ± 2.67

58.6c ± 1.35

437.6b ± 10.07

0.135b ± 0.005

A

255.0b ± 2.7

303.9bc ± 1.96

48.9b ± 1.09

418.4ab ± 11.92

0.118ab ± 0.005

N1

255.0b ± 2.9

298.3c ± 2.14

43.3ab ± 1.35

408.9ab ± 19.88

0.108a ± 0.010

NN1

255.0b ± 3.5

298.3c ± 2.65

43.3ab ± 1.86

390.3ab ± 13.65

0.111a ± 0.004

N2

255.0b ± 3.7

304.0c ± 2.77

49.0b ± 2.27

403.8ab ± 10.60

0.121ab ± 0.004

NN2

255.0b ± 3.3

301.0c ± 2.98

46.0ab ± 2.71

394.7ab ± 11.20

0.116ab ± 0.010

AN1

255.0b ± 3.6

296.4c ± 2.09

41.4a ± 2.31

387.7a ± 12.68

0.107a ± 0.010

ANN1

255.0b ± 3.8

296.9c ± 2.96

41.9a ± 2.38

377.2a ± 8.54

0.112a ± 0.010

AN2

255.0b ± 2.5

298.3c ± 2.35

43.3ab ± 1.19

396.3ab ± 7.99

0.110a ± 0.010

ANN2

255.0b ± 3.8

299.1c ± 2.55

44.1ab ± 1.39

395.7ab ± 7.91

0.110a ± 0.004

  1. Values are expressed as means ± SE (n = 8). Significance was considered at p < 0.05 within columns where different letters indicate statistical significance.
  2. NC control normal, MC metabolic syndrome control, A rats given atorvastatin drug, N1 rats received nutraceutical 1, NN1 Rats treated with nutraceutical 1nanostructure, N2 rats received nutraceutical 2, NN2 rats given nutraceutical 2 nanostructure, AN1 rats taken atorvastatin drug with nutraceutical 1, ANN1 rats given atorvastatin drug with nutraceutical 1 nanostructure, AN2 rats treated with atorvastatin drug with nutraceutical 2, ANN2 rats received atorvastatin drug with nutraceutical 2 nanostructure, IBW initial body weight, FBW final body weight, BWG body weight gain, TFI total food intake, FER food efficiency ratio.
Back to article page